Tapewire

NYSE · USD

HCA

HCA Healthcare, Inc.

Export transactions ↓
Tapewire entity
2929
SEC CIK
0000860730
Parsed reports
883

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 2026012
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 31, 2024 Filed Feb 2, 2024 18:47 UTC
Mosier Sammie SSVP & Chief Nurse Executive
GrantStock Appreciation Right · Derivative 4,402 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002728 · doc4.xml · derivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,402

Underlying: Common Stock · 4,402 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:46 UTC
McManus Timothy MGroup President
GrantStock Appreciation Right · Derivative 11,005 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002727 · doc4.xml · derivative · entry 1

McManus Timothy M · CIK 0001957740 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,005

Underlying: Common Stock · 11,005 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:45 UTC
McAlevey Michael RSVP & Chief Legal Officer
GrantStock Appreciation Right · Derivative 11,005 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002726 · doc4.xml · derivative · entry 1

McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,005

Underlying: Common Stock · 11,005 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:44 UTC
Marks Mike ASVP-Finance
GrantStock Appreciation Right · Derivative 5,503 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002725 · doc4.xml · derivative · entry 1

Marks Mike A · CIK 0001961124 · SVP-Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,503

Underlying: Common Stock · 5,503 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:43 UTC
HAZEN SAMUEL NDirector · CEO
GrantStock Appreciation Right · Derivative 79,784 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002724 · doc4.xml · derivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,784

Underlying: Common Stock · 79,784 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:40 UTC
Hammett Richard AGroup President
GrantStock Appreciation Right · Derivative 11,005 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002723 · doc4.xml · derivative · entry 1

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,005

Underlying: Common Stock · 11,005 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:39 UTC
Foster Jon MEVP and COO
GrantStock Appreciation Right · Derivative 20,634 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002722 · doc4.xml · derivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,634

Underlying: Common Stock · 20,634 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:38 UTC
Cuffe Michael S.EVP and Chief Clinical Officer
GrantStock Appreciation Right · Derivative 12,656 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002721 · doc4.xml · derivative · entry 3

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,656

Underlying: Common Stock · 12,656 shares

Expires 2034-01-31

F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:38 UTC
Cuffe Michael S.EVP and Chief Clinical Officer
SaleCommon Stock 3,200 $306.79 $981,733.76
Disclosure

SEC source: 0001209191-24-002721 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,928.9672

F1 · balance_after: Includes 2,436.9672 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:38 UTC
Cuffe Michael S.EVP and Chief Clinical Officer
GiftCommon Stock 728 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002721 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,128.9672

F1 · balance_after: Includes 2,436.9672 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:36 UTC
Cohen Jeffrey E.SVP-Government Relations
GrantStock Appreciation Right · Derivative 3,302 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002720 · doc4.xml · derivative · entry 1

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,302

Underlying: Common Stock · 3,302 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:35 UTC
Billington Phillip GSVP-Internal Audit Services
GrantStock Appreciation Right · Derivative 3,302 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002719 · doc4.xml · derivative · entry 1

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,302

Underlying: Common Stock · 3,302 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:35 UTC
Berres JenniferSVP & Chief Human Res. Officer
GrantStock Appreciation Right · Derivative 9,354 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002718 · doc4.xml · derivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,354

Underlying: Common Stock · 9,354 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 18:33 UTC
Akdamar Erol RGroup President
GrantStock Appreciation Right · Derivative 11,005 $0.00 Strike: $304.90 $0.00
Disclosure

SEC source: 0001209191-24-002717 · doc4.xml · derivative · entry 1

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,005

Underlying: Common Stock · 11,005 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 17:55 UTC
Mosier Sammie SSVP & Chief Nurse Executive
Exercise / conversionRestricted Stock Units · Derivative 323 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002509 · doc4.xml · derivative · entry 3

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 323 shares

Expires 2030-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units vested in three equal annual installments beginning January 29, 2022.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 17:55 UTC
Mosier Sammie SSVP & Chief Nurse Executive
Tax withholdingCommon Stock 96 $286.73 $27,526.08
Disclosure

SEC source: 0001209191-24-002509 · doc4.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,017

Read SEC document
January 29, 2024 Filed Jan 31, 2024 17:55 UTC
Mosier Sammie SSVP & Chief Nurse Executive
Exercise / conversionCommon Stock 323 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002509 · doc4.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,113

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 17:54 UTC
Hammett Richard AGroup President
Exercise / conversionRestricted Stock Units · Derivative 600 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002508 · doc4.xml · derivative · entry 3

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 600 shares

Expires 2030-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units vested in two equal annual installments beginning January 29, 2023.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 17:54 UTC
Hammett Richard AGroup President
Tax withholdingCommon Stock 164 $286.73 $47,023.72
Disclosure

SEC source: 0001209191-24-002508 · doc4.xml · nonDerivative · entry 2

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,198

Read SEC document
January 29, 2024 Filed Jan 31, 2024 17:54 UTC
Hammett Richard AGroup President
Exercise / conversionCommon Stock 600 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002508 · doc4.xml · nonDerivative · entry 1

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,362

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 28, 2024 Filed Jan 30, 2024 19:22 UTC
McAlevey Michael RSVP & Chief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 1,940 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002455 · doc4.xml · derivative · entry 4

McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,940 shares

Expires 2032-01-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vested in two equal annual installments beginning on January 28, 2023.

Read SEC document
January 28, 2024 Filed Jan 30, 2024 19:22 UTC
McAlevey Michael RSVP & Chief Legal Officer
Tax withholdingCommon Stock 489 $283.43 $138,597.27
Disclosure

SEC source: 0001209191-24-002455 · doc4.xml · nonDerivative · entry 2

McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,012

Read SEC document
January 28, 2024 Filed Jan 30, 2024 19:22 UTC
McAlevey Michael RSVP & Chief Legal Officer
Exercise / conversionCommon Stock 1,940 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002455 · doc4.xml · nonDerivative · entry 1

McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
November 14, 2023 Filed Nov 14, 2023 18:36 UTC
Sowell Joseph A IIISVP; Chief Development Officer
GiftCommon Stock 5,159 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 6

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2023 Trust

Disclosed balance after: 5,159

Read SEC document
November 14, 2023 Filed Nov 14, 2023 18:36 UTC
Sowell Joseph A IIISVP; Chief Development Officer
GiftCommon Stock 5,159 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 5

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
November 14, 2023 Filed Nov 14, 2023 18:36 UTC
Sowell Joseph A IIISVP; Chief Development Officer
GiftCommon Stock 29,771 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 4

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 2023 Spouse Trust

Disclosed balance after: 29,771

Read SEC document
November 14, 2023 Filed Nov 14, 2023 18:36 UTC
Sowell Joseph A IIISVP; Chief Development Officer
GiftCommon Stock 29,771 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 3

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 29,771

Read SEC document
November 13, 2023 Filed Nov 15, 2023 17:37 UTC
Akdamar Erol RGroup President
Exercise / conversionStock Appreciation Right · Derivative 12,325 $0.00 Strike: $47.97 $0.00
Disclosure

SEC source: 0001209191-23-055408 · doc4.xml · derivative · entry 6

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,325 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 17:37 UTC
Akdamar Erol RGroup President
Exercise / conversionStock Appreciation Right · Derivative 14,500 $0.00 Strike: $47.97 $0.00
Disclosure

SEC source: 0001209191-23-055408 · doc4.xml · derivative · entry 5

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,500 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 17:37 UTC
Akdamar Erol RGroup President
Tax withholdingCommon Stock 13,951 $229.99 $3,208,590.49
Disclosure

SEC source: 0001209191-23-055408 · doc4.xml · nonDerivative · entry 2

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,874

Read SEC document
November 13, 2023 Filed Nov 15, 2023 17:37 UTC
Akdamar Erol RGroup President
Exercise / conversionCommon Stock 26,825 $47.97 $1,286,795.25
Disclosure

SEC source: 0001209191-23-055408 · doc4.xml · nonDerivative · entry 1

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,825

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2023 Filed Nov 14, 2023 18:36 UTC
Sowell Joseph A IIISVP; Chief Development Officer
GiftCommon Stock 29,771 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 29,771

Read SEC document
November 10, 2023 Filed Nov 14, 2023 18:36 UTC
Sowell Joseph A IIISVP; Chief Development Officer
GiftCommon Stock 29,771 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees)

Disclosed balance after: 0

Read SEC document
November 10, 2023 Filed Nov 14, 2023 18:16 UTC
Billington Phillip GSVP-Internal Audit Services
Exercise / conversionStock Appreciation Right · Derivative 5,525 $0.00 Strike: $47.97 $0.00
Disclosure

SEC source: 0001209191-23-055220 · doc4.xml · derivative · entry 4

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,525 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

Read SEC document
November 10, 2023 Filed Nov 14, 2023 18:16 UTC
Billington Phillip GSVP-Internal Audit Services
Exercise / conversionStock Appreciation Right · Derivative 6,500 $0.00 Strike: $47.97 $0.00
Disclosure

SEC source: 0001209191-23-055220 · doc4.xml · derivative · entry 3

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,500 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.

Read SEC document
November 10, 2023 Filed Nov 14, 2023 18:16 UTC
Billington Phillip GSVP-Internal Audit Services
Tax withholdingCommon Stock 6,237 $232.82 $1,452,098.34
Disclosure

SEC source: 0001209191-23-055220 · doc4.xml · nonDerivative · entry 2

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,860.4544

F1 · balance_after: Includes 2,283.4544 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

Read SEC document
November 10, 2023 Filed Nov 14, 2023 18:16 UTC
Billington Phillip GSVP-Internal Audit Services
Exercise / conversionCommon Stock 12,025 $47.97 $576,839.25
Disclosure

SEC source: 0001209191-23-055220 · doc4.xml · nonDerivative · entry 1

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,097.4544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,283.4544 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 17:12 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
SaleCommon Stock 5,204 $269.12 $1,400,515.57
Disclosure

SEC source: 0001209191-23-046060 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,760

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.10 to $269.25, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 17:11 UTC GiftCommon Stock 49,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-046058 · doc4.xml · nonDerivative · entry 4

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Indirect · By NLR LLC

Disclosed balance after: 90,000

Read SEC document
August 14, 2023 Filed Aug 16, 2023 17:11 UTC GiftCommon Stock 49,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-046058 · doc4.xml · nonDerivative · entry 3

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 0

Read SEC document
August 14, 2023 Filed Aug 16, 2023 17:11 UTC GiftCommon Stock 40,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-046058 · doc4.xml · nonDerivative · entry 2

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Indirect · By NLR LLC

Disclosed balance after: 40,500

Read SEC document
August 14, 2023 Filed Aug 16, 2023 17:11 UTC GiftCommon Stock 40,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-046058 · doc4.xml · nonDerivative · entry 1

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,369

Read SEC document
August 11, 2023 Filed Aug 15, 2023 17:20 UTC
Cohen Jeffrey E.SVP-Government Relations
SaleCommon Stock 1,500 $270.00 $405,000.00
Disclosure

SEC source: 0001209191-23-045895 · doc4.xml · nonDerivative · entry 1

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,414

Read SEC document
August 04, 2023 Filed Aug 7, 2023 16:38 UTC
Marks Mike ASVP-Finance
GiftCommon Stock 205 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-044830 · doc4.xml · nonDerivative · entry 3

Marks Mike A · CIK 0001961124 · SVP-Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45

Read SEC document
August 03, 2023 Filed Aug 7, 2023 16:39 UTC
Whalen Kathleen MSVP & Chief Ethics Officer
SaleCommon Stock 2,916 $270.00 $787,320.00
Disclosure

SEC source: 0001209191-23-044831 · doc4.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,250

Read SEC document
August 03, 2023 Filed Aug 7, 2023 16:38 UTC
Marks Mike ASVP-Finance
GiftCommon Stock 8,343 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-044830 · doc4.xml · nonDerivative · entry 2

Marks Mike A · CIK 0001961124 · SVP-Finance

10b5-1 filing: No plan indicated

Ownership: Indirect · By MAM 2020 Trust

Disclosed balance after: 40,990

Read SEC document
August 03, 2023 Filed Aug 7, 2023 16:38 UTC
Marks Mike ASVP-Finance
GiftCommon Stock 8,343 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-044830 · doc4.xml · nonDerivative · entry 1

Marks Mike A · CIK 0001961124 · SVP-Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Read SEC document
August 02, 2023 Filed Aug 4, 2023 16:43 UTC GiftCommon Stock 49,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-044609 · doc4.xml · nonDerivative · entry 2

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 49,500

Read SEC document
August 02, 2023 Filed Aug 4, 2023 16:43 UTC GiftCommon Stock 49,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-044609 · doc4.xml · nonDerivative · entry 1

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,869

Read SEC document
August 01, 2023 Filed Aug 3, 2023 17:24 UTC
Foster Jon MEVP and COO
GiftCommon Stock 5,350 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-044506 · doc4.xml · nonDerivative · entry 4

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 5,350

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.